drugset / Trial / NCT05059327
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
RandomizedCrossoverDouble-blindTreatment
Summary
The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Complex (TSC).
Timeline
- Start
- 2022-03-03
- Primary completion
- 2025-02-06
- Completion
- 2025-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Basimglurant | Small molecule | — | — |